131 related articles for article (PubMed ID: 12230936)
41. Comparison of two different preparations of HIV immune globulin for efficiency of neutralization of HIV type 1 primary isolates.
Nichols CN; Bernal I; Prince AM; Andrus L
AIDS Res Hum Retroviruses; 2002 Jan; 18(1):49-56. PubMed ID: 11804556
[TBL] [Abstract][Full Text] [Related]
42. Change in tropism upon immune escape by human immunodeficiency virus.
McKnight A; Weiss RA; Shotton C; Takeuchi Y; Hoshino H; Clapham PR
J Virol; 1995 May; 69(5):3167-70. PubMed ID: 7707545
[TBL] [Abstract][Full Text] [Related]
43. Polyclonal immunoglobulin G from patients neutralizes human immunodeficiency virus type 1 primary isolates by binding free virions, but without interfering with an initial CD4-independent attachment of the virus to primary blood mononuclear cells.
Burrer R; Haessig-Einius S; Aubertin AM; Moog C
J Virol; 2003 Nov; 77(21):11385-97. PubMed ID: 14557624
[TBL] [Abstract][Full Text] [Related]
44. Antibody-mediated neutralization of primary isolates of human immunodeficiency virus type 1 in peripheral blood mononuclear cells is not affected by the initial activation state of the cells.
Zhou JY; Montefiori DC
J Virol; 1997 Mar; 71(3):2512-7. PubMed ID: 9032392
[TBL] [Abstract][Full Text] [Related]
45. Increased neutralization sensitivity and reduced replicative capacity of human immunodeficiency virus type 1 after short-term in vivo or in vitro passage through chimpanzees.
Beaumont T; Broersen S; van Nuenen A; Huisman HG; de Roda Husman AM; Heeney JL; Schuitemaker H
J Virol; 2000 Sep; 74(17):7699-707. PubMed ID: 10933675
[TBL] [Abstract][Full Text] [Related]
46. A resting cell assay for improved detection of antibody-mediated neutralization of HIV type 1 primary isolates.
Zolla-Pazner S; Sharpe S
AIDS Res Hum Retroviruses; 1995 Dec; 11(12):1449-58. PubMed ID: 8679288
[TBL] [Abstract][Full Text] [Related]
47. Polymerase chain reaction-based assay for antibody-mediated neutralization of HIV-1 reveals a population of nonneutralized virus undetected by conventional p24 assay.
Achkar JM; Wang XH; Nyambi P; Gorny MK; Zolla-Pazner S; Bandrés JC
J Acquir Immune Defic Syndr; 2000 Jul; 24(3):203-10. PubMed ID: 10969343
[TBL] [Abstract][Full Text] [Related]
48. Escape of HIV-1 is associated with lack of V3 domain-specific antibodies in vivo.
Schreiber M; Müller H; Wachsmuth C; Laue T; Hufert FT; Van Laer MD; Schmitz H
Clin Exp Immunol; 1997 Jan; 107(1):15-20. PubMed ID: 9010251
[TBL] [Abstract][Full Text] [Related]
49. Correlation between susceptibility of primary HIV-1 isolates to autologous and heterologous neutralizing antibodies. Hospital Evandro Chagas AIDS Clinical Research Group.
Bongertz V; Costa CI; Santos VG; João Filho EC; Galvão-Castro B; Morgado MG
AIDS; 1997 Jul; 11(8):969-75. PubMed ID: 9223730
[TBL] [Abstract][Full Text] [Related]
50. Primary isolate neutralization by HIV type 1-infected patient sera in the era of highly active antiretroviral therapy.
Dreyer K; Kallas EG; Planelles V; Montefiori D; McDermott MP; Hasan MS; Evans TG
AIDS Res Hum Retroviruses; 1999 Nov; 15(17):1563-71. PubMed ID: 10580407
[TBL] [Abstract][Full Text] [Related]
51. HIV type 1-specific IgE in serum of long-term surviving children inhibits HIV type 1 production in vitro.
Pellegrino MG; Bluth MH; Smith-Norowitz T; Fikrig S; Volsky DJ; Moallem H; Auci DL; Nowakowski M; Durkin HG
AIDS Res Hum Retroviruses; 2002 Mar; 18(5):363-72. PubMed ID: 11897038
[TBL] [Abstract][Full Text] [Related]
52. Enhanced macrophage tropism of HIV in brain and lymphoid tissues is associated with sensitivity to the broadly neutralizing CD4 binding site antibody b12.
Dunfee RL; Thomas ER; Gabuzda D
Retrovirology; 2009 Jul; 6():69. PubMed ID: 19619305
[TBL] [Abstract][Full Text] [Related]
53. CD4-dependent and CD4-independent HIV-2: consequences for neutralization.
Thomas ER; Shotton C; Weiss RA; Clapham PR; McKnight A
AIDS; 2003 Feb; 17(3):291-300. PubMed ID: 12556682
[TBL] [Abstract][Full Text] [Related]
54. Generation of human monoclonal antibodies against HIV-1 proteins; electrofusion and Epstein-Barr virus transformation for peripheral blood lymphocyte immortalization.
Buchacher A; Predl R; Strutzenberger K; Steinfellner W; Trkola A; Purtscher M; Gruber G; Tauer C; Steindl F; Jungbauer A
AIDS Res Hum Retroviruses; 1994 Apr; 10(4):359-69. PubMed ID: 7520721
[TBL] [Abstract][Full Text] [Related]
55. Identification of envelope V3 loop as the major determinant of CD4 neutralization sensitivity of HIV-1.
Hwang SS; Boyle TJ; Lyerly HK; Cullen BR
Science; 1992 Jul; 257(5069):535-7. PubMed ID: 1636088
[TBL] [Abstract][Full Text] [Related]
56. Improvement of Herpesvirus saimiri T cell immortalization procedure to generate multiple CD4+ T-cell clones from peripheral blood lymphocytes of AIDS patients.
Saha K; McKinley G; Volsky DJ
J Immunol Methods; 1997 Aug; 206(1-2):21-3. PubMed ID: 9328564
[TBL] [Abstract][Full Text] [Related]
57. Quantitative analysis of serum neutralization of human immunodeficiency virus type 1 from subtypes A, B, C, D, E, F, and I: lack of direct correlation between neutralization serotypes and genetic subtypes and evidence for prevalent serum-dependent infectivity enhancement.
Kostrikis LG; Cao Y; Ngai H; Moore JP; Ho DD
J Virol; 1996 Jan; 70(1):445-58. PubMed ID: 8523557
[TBL] [Abstract][Full Text] [Related]
58. Isolation of HIV type 1 from long-term nonprogressors in Herpesvirus saimiri-immortalized T cells.
Vella C; Gregory J; Bristow R; Troop M; Easterbrook P; Zheng N; Daniels R
AIDS Res Hum Retroviruses; 1999 Aug; 15(12):1145-7. PubMed ID: 10461835
[No Abstract] [Full Text] [Related]
59. Neutralization sensitivity of human immunodeficiency virus type 1 primary isolates to antibodies and CD4-based reagents is independent of coreceptor usage.
Trkola A; Ketas T; Kewalramani VN; Endorf F; Binley JM; Katinger H; Robinson J; Littman DR; Moore JP
J Virol; 1998 Mar; 72(3):1876-85. PubMed ID: 9499039
[TBL] [Abstract][Full Text] [Related]
60. Targeting HIV Reservoir in Infected CD4 T Cells by Dual-Affinity Re-targeting Molecules (DARTs) that Bind HIV Envelope and Recruit Cytotoxic T Cells.
Sloan DD; Lam CY; Irrinki A; Liu L; Tsai A; Pace CS; Kaur J; Murry JP; Balakrishnan M; Moore PA; Johnson S; Nordstrom JL; Cihlar T; Koenig S
PLoS Pathog; 2015; 11(11):e1005233. PubMed ID: 26539983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
